All I can say is that those that understand the business and strategy of the BOD will know how complex it is to line all the ducks up and deal with all the consultants , authorities and the like to get the business moving forward . There are no excuses , the BOD has advised what it is doing and set it out clearly and as I see it there has been a sound change of strategy not delay . But each to their own as one needs to be comfortable with their investment and each has a different risk appetite .
The price fluctuation is to be expected for a number of reasons the main focus should be in my view that the SP is trending up and has come from single digits . What else do investors want . The SP has to build over time as the business develops . The listing is the start of exposure to a bigger market and the trial results will drive the price and there will still be fluctuations at whatever price point . So in my view patience is needed if not then do what needs to be done based on risk profile .
They will list when they list . Given the price action we have seen recently it appears to be close as the smart money in my view has been buying to get set . In my view anyway the listing will happen first and then simultaneous news will flow . I expect that given the boxes already ticked by the BOD and price action that the news should be good . We will see shortly . Even on listing and if the news is excellent it will still likely take time to build the price .
Does anyone seriously have a view that given the consultants that have come on board risking reputation and given the pending listing and all the steps undertaken by the company to date, and the time and money spent to get to where the company is now , that they would be listing if the product trials were not travelling well and if they did not have very strong fundamentals . I doubt it . The above are my views and I sense we will be rewarded for patience in the medium term .
IHL Price at posting:
57.0¢ Sentiment: Buy Disclosure: Held
